Revised SPCs: Simponi (golimumab) solution for injection in pre-filled pen or syringe (all strengths)
SPCs updated to include Kaposi’s sarcoma (a rare type of cancer caused by a virus, which can affect the skin and mouth and potentially the internal organs) as an adverse effect of treatment of unknown frequency.
Source:
electronic Medicines compendium